Merus announces FDA Orphan Drug Designation of Zenocutuzumab for the Treatment of Pancreatic Cancer

NEXT STORY
Ayala Pharmaceuticals to Present Updated Data from Ongoing Phase 2 ACCURACY Trial of AL101 for the Treatment of R/M Adenoid Cystic Carcinoma at the European Society for Medical Oncology (ESMO) Virtual Congress 2020
PREV STORY
Checkpoint Therapeutics to Present Cosibelimab Interim Results from Registration-Enabling Trial at ESMO Virtual Congress 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

iBio Announces Partial Adjournment of Annual Meeting of Shareholders to January 31, 2022

author_avatar
NASDAQ Market News

American Gene Technologies Congratulates Robert Redfield, M.D., on His Appointment as Director of the Centers for Disease Control and Prevention

ROCKVILLE, Md., March 28, 2018 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), ...

author_avatar
NASDAQ Market News

UCSF and BridgeBio Pharma Collaborate to Accelerate the Development of Therapies for Genetic Diseases

author_avatar
NASDAQ Market News